Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer

Oncology

Volumn 67, Issue 3-4, 2004, Pages 215-221

  Ueno, Hideki ^a   Okusaka, Takuji ^a   Ikeda, Masafumi ^a   Tokuuye, Koich ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

5 Fluorouracil; Chemoradiotherapy; Hyperfractionation; Pancreatic cancer; Phase I study; Radiation therapy

Indexed keywords

FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FATIGUE; FEMALE; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MALE; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PEPTIC ULCER BLEEDING; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RASH; SIDE EFFECT; STOMACH ULCER; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; TOXICITY; VOMITING; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 9244254817     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081320     Document Type: Article

References (19)

1. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO Jr, Thomas P, Nave H, Bateman J, Lokich J, Brooks J, Chaffey J, Corson JM, Zamcheck N, Novak JW: Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6,000 rads) radiation alone, moderate dose radiation (4,000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-1710.
2. Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80:751-755.
3. Okada S: Non-surgical treatments of pancreatic cancer. Int J Clin Oncol 1999;4:257-266.
4. Ang KK, Thames HD, Peters LJ. Perez C: Altered fractionation schedules; in Perez CA, Brady L (eds): Principles and Practice of Radiation Oncology. Philadelphia, Lippincott-Raven, 1997, pp 119-142.
5. Horiot JC, Le Fur R, N'Guyen T, Chenal C, Schraub S, Alfonsi S, Gardani G, Van Den Bogaert W, Danczak S, Bolla M, et al: Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-241.
6. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF: A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-smallcell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8:1543-1555.
7. Seydel HG, Stablein DM, Leichman LP, Kinzie JJ, Thomas PR: Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience. Cancer 1990;65:1478-1482.
8. Prott FJ, Schonekaes K, Preusser P, Ostkamp K, Wagner W, Micke O, Potter R, Sulkowski U, Rube C, Berns T, Willich N: Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: Results of a feasibility study. Br J Cancer 1997;75:597-601.
9. Luderhoff EC, Gonzalez Gonzalez D, Bakker P: Pilot study in locally advanced unresectable pancreas carcinoma using a combination of accelerated radiotherapy and continuous infusion of 5-fluorouracil. Radiother Oncol 1996;40:241-243.
10. Japan Society for Cancer Therapy: Criteria for the evaluation of the clinical effects of solid cancer chemotherapy. J Jpn Soc Cancer Ther 1993;28:101-130.
11. World Health Organization: WHO handbook for Reporting Results of Cancer Treatment. Offset Publication 48. Geneva, World Health Organization, 1979.
12. Roldan GE, Gunderson LL, Nagorney DM, Martin JK, Ilstrup DM, Holbrook MA, Kvols LK, McIlrath DC: External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 1988;61:1110-1116.
13. Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, Hiraoka M, Ohshio G, Imamura M, Takahashi M, Abe M: External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: Analysis of survival rates and complications. Int J Radiat Oncol Biol Phys 1997;39:39-49.
14. 125I implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1992;23:305-311.
15. Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CH, Schneider CJ, Rauws EA, Phoa SS, Gonzalez Gonzalez D: Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 2000;89:2222-2229.
16. Withers HR: Cell cycle redistribution as a factor in multifraction irradiation. Radiology 1975;114:199-202.
17. Palcic B, Skarsgard LD: Reduced oxygen enhancement ratio at low doses of ionizing radiation. Radiat Res 1984;100:328-339.
18. Ashamalla H, Zaki B, Mokhtar B, Colella F, Selim H, Krishnamurthy M, Ross P: Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2003;55:679-687.
19. Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H: Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997;79:1516-1520.